Northwire Canada EditionWednesday, July 29, 2026
Sign inSubscribe
Northwire
⌕
NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0% NAM 0.250 +0.0% CRD 0.065 +8.3% OLA 12.90 −3.7% CG 22.70 −2.5% EQX 12.89 −4.0% FM 37.51 −2.3% MNRG 0.080 −11.1% KFR 1.31 +0.8% AUMN 0.275 +0.0% GLB 0.250 +0.0% BHS 0.045 −10.0% EGR 0.025 +0.0% RIO 2.59 −4.1% GEN 0.070 +0.0% MAI 4.39 −2.0% RYR 0.175 +0.0%
Production / Operations

Kneat Recognised as Leader in G2 Pharma and Biotech Fall 2025 Grid Reports

By The Northwire Desk — AI Analysis Sep 24, 2025 · 06:38 KSI · 5.51 KNEAT.COM, INC. J
KSI · Price

Executive Summary

  • Kneat, Inc. has been recognized as a market leader in G2 Software Review's Fall 2025 Pharma and Biotech Software category reports, achieving the top position in three specific metrics.
  • The company achieved a G2 Satisfaction Score of 98 out of 100, significantly outperforming the second-ranked company by 20 points.
  • Kneat was ranked 2nd overall in the G2 Pharma and Biotech Usability Index, based on customer feedback regarding ease of administration, ease of use, and requirement fulfillment.

Key Details

  • G2 Grid® Report Recognition:
    • Leader in the Grid® Report for Pharma and Biotech.
    • Leader in the Relationship Index for Pharma and Biotech.
    • Leader in the Mid-Market Grid® Report for Pharma and Biotech.
  • Satisfaction Metrics:
    • Total G2 Satisfaction Score: 98/100.
    • Margin over second-ranked company: 20 points (Second place scored 78).
  • Relationship Index Breakdown:
    • Based on customer feedback in "Ease of Doing Business," "Likely to Recommend," and "Quality of Support."
  • Usability Index Ranking:
    • Ranked 2nd overall in the G2 Pharma and Biotech Usability Index.
    • Evaluated on "Ease of Admin," "Ease of Use," and "Meets Requirements."
  • Product Compliance and Efficiency (from "About" section):
    • Kneat Gx is ISO 9001 and ISO 27001 certified.
    • Compliant with 21 CFR Part 11 and Annex 11.
    • Reduces labor hours for validation documentation by more than 50%.
    • Accelerates review and approval cycles by up to 50%.

Notable Quotes

  • "Earning three G2 leader badges is no small feat for a software company supporting any industry, let alone one as demanding and precise as life sciences," said Eddie Ryan, CEO of Kneat. "The achievement reflects not only the trust that our customers place in us, but the dedication of our team to deliver Kneat's pioneering user-focused software. At Kneat, customer satisfaction isn't just a value — it's at the heart of everything we do. I am proud of our team for embracing this mission every single day."
Read the original news release →

More from KNEAT.COM, INC. J

Jun 30, 2026 · 07:57

Kneat Files Management Information Circular in Connection with the Previously Announced Thoma Bravo Transaction

M&A / Property Jun 08, 2026 · 07:37

Thoma Bravo to acquire Kneat for C$6.50/sh cash, a ~40% premium to unaffected and ~20% to last close, taking the digital validation leader private.

M&A / Property May 13, 2026 · 17:17

Kneat’s record revenue overshadowed by swing to $3.9M loss as strategic review unfolds

Earnings May 11, 2026 · 14:46

Kneat launches strategic review after press reports, potential sale process revives shares amid digital validation growth

Other Apr 30, 2026 · 05:57

Kneat Solutions Inc.

Other Apr 28, 2026 · 17:06

Kneat Solutions Inc. executes growth strategy but faces valuation headwinds despite profitability milestones

Other